TapImmune Inc Share Price Nasdaq
Equities
US8760334081
Biotechnology & Medical Research
Sales 2022 | 9.01M 752M | Sales 2023 | 3.31M 276M | Capitalization | 48.89M 4.08B |
---|---|---|---|---|---|
Net income 2022 | -29M -2.42B | Net income 2023 | -8M -668M | EV / Sales 2022 | 2.06 x |
Net cash position 2022 | 4.17M 348M | Net cash position 2023 | 15.11M 1.26B | EV / Sales 2023 | 10.2 x |
P/E ratio 2022 |
-0.74
x | P/E ratio 2023 |
-5.88
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 87.83% |
Latest transcript on TapImmune Inc
Managers | Title | Age | Since |
---|---|---|---|
Juan F. Vera
CEO | Chief Executive Officer | 44 | 17/18/17 |
Monic Stuart
CTO | Chief Tech/Sci/R&D Officer | - | - |
Gerald Garrett
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/19/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 63 | 17/18/17 | |
Steven Elms
BRD | Director/Board Member | 60 | 06/19/06 |
Katharine Knobil
BRD | Director/Board Member | 60 | 08/21/08 |
1st Jan change | Capi. | |
---|---|---|
+1.77% | 42.75B | |
+47.70% | 41.61B | |
+12.24% | 41.34B | |
-8.83% | 26.59B | |
+7.44% | 25.49B | |
-23.01% | 18.12B | |
+30.56% | 12.24B | |
-1.82% | 11.76B | |
+8.35% | 11B |